The effect of non-esterified fatty acids on vascular ADP-degrading enzyme activity
- 28 February 1987
- journal article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 3 (1) , 9-19
- https://doi.org/10.1016/s0168-8227(87)80003-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Does human placenta produce prostacyclin?Placenta, 1985
- Decreased prostacyclin production by placental cells in culture from pregnancies complicated by fetal growth retardationBJOG: An International Journal of Obstetrics and Gynaecology, 1983
- Effect of nonesterified fatty acids on the stability of prostacyclin activityMetabolism, 1983
- Simulating the diabetic environment modifies in vitro prostacyclin synthesisDiabetes, 1983
- Adenosine Diphosphate-Degrading Activity in PlacentaClinical Science, 1983
- Effect of Human Plasma Proteins on Stabilisation of Platelet Anti-Aggregatory Activity of ProstacyclinAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1982
- Plasma non-esterified fatty acid levels and atherogenesis in diabetes mellitusDiabetologia, 1981
- Inhibitors of platelet aggregation in the fetoplacental unit and myometrium with particular reference to the ADP-degrading property of placentaPlacenta, 1980
- Inhibition of platelet aggregation by placental extractsThrombosis Research, 1980
- A MEMBRANE-BOUND ENZYME IN RABBIT AORTA CAPABLE OF INHIBITING ADENOSINE-DIPHOSPHATE-INDUCED PLATELET AGGREGATIONThe Lancet, 1977